ArticleBMJ open2024

Correction: 'How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registrybased cohort study from Norway'.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.